CLINICAL_TRIALS
trial_result
· 2020-12-02
Clinical Trial Update: A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma [Phase 2]
Summary
Phase 2 study of LY2157299 in advanced hepatocellular carcinoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-12-02